CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Beta (13760)
(-)
Architecture: Ribbon (789)
(-)
Topology: Antistasin; domain 1 (8)
(-)
Homologous Superfamily: Antistasin; domain 1 (8)
(-)
Bovine (Bos taurus) (1)
3BG4D:12-57THE CRYSTAL STRUCTURE OF GUAMERIN IN COMPLEX WITH CHYMOTRYPSIN AND THE DEVELOPMENT OF AN ELASTASE-SPECIFIC INHIBITOR
(-)
Cattle (Bos taurus) (1)
1C9TG:7-59; H:7-59; I:7-59; J:7-59; K:7-59; L:7-59COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN
(-)
Medicinal leech (Hirudo medicinalis) (2)
1BX7A:3-53HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.2 ANGSTROMS
1BX8A:5-53HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.4 ANGSTROMS
(-)
Mexican leech (Haementeria officinalis) (1)
1SKZA:7-57; A:58-110PROTEASE INHIBITOR
(-)
Pig (Sus scrofa) (3)
1C9PB:10-59COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN
1EJAB:7-59STRUCTURE OF PORCINE TRYPSIN COMPLEXED WITH BDELLASTASIN, AN ANTISTASIN-TYPE INHIBITOR
1HIAI:5-52; J:5-52KALLIKREIN COMPLEXED WITH HIRUSTASIN
(-)
Topology: Calnexin lumenal domain, non-globular proline-rich hairpin domain (3)
(-)
Homologous Superfamily: Calnexin lumenal domain, non-globular proline-rich hairpin domain (3)
(-)
Dog (Canis lupus familiaris) (1)
1JHNA:270-415CRYSTAL STRUCTURE OF THE LUMENAL DOMAIN OF CALNEXIN
(-)
Norway rat (Rattus norvegicus) (2)
1HHNA:188-288CALRETICULIN P-DOMAIN
1K9CA:188-261SOLUTION STRUCTURE OF CALRETICULIN P-DOMAIN SUBDOMAIN (RESIDUES 189-261)
(-)
Topology: CD59 (129)
(-)
Homologous Superfamily: CD59 (129)
(-)
[unclassified] (3)
1QM7A:1-61X-RAY STRUCTURE OF A THREE-FINGERED CHIMERIC PROTEIN, STABILITY OF A STRUCTURAL SCAFFOLD
2VLWA:1-65; B:1-65CRYSTAL STRUCTURE OF THE MUSCARINIC TOXIN MT7 DIIODOTYR51 DERIVATIVE.
3FEVA:1-65; B:1-65; C:1-65CRYSTAL STRUCTURE OF THE CHIMERIC MUSCARINIC TOXIN MT7 WITH LOOP 1 FROM MT1.
(-)
2_ (1)
1ABTA:1-74NMR SOLUTION STRUCTURE OF AN ALPHA-BUNGAROTOXIN(SLASH) NICOTINIC RECEPTOR PEPTIDE COMPLEX
(-)
Asian cobra (Naja oxiana) (1)
1W6BA:1-73SOLUTION NMR STRUCTURE OF A LONG NEUROTOXIN FROM THE VENOM OF THE ASIAN COBRA, 20 STRUCTURES
(-)
Black mamba (Dendroaspis polylepis polylepis) (2)
1NTXA:1-62SECONDARY STRUCTURE DETERMINATION FOR ALPHA-NEUROTOXIN FROM DENDROASPIS POLYLEPIS POLYLEPIS BASED ON SEQUENCE SPECIFIC PROTON NUCLEAR MAGNETIC RESONANCE ASSIGNMENTS
1TFSA:1-60NMR AND RESTRAINED MOLECULAR DYNAMICS STUDY OF THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF TOXIN FS2, A SPECIFIC BLOCKER OF THE L-TYPE CALCIUM CHANNEL, ISOLATED FROM BLACK MAMBA VENOM
(-)
Broad-banded blue sea krait (Laticauda semifasciata) (11)
1ERAA:1-62TERTIARY STRUCTURE OF ERABUTOXIN B IN AQUEOUS SOLUTION ELUCIDATED BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE
1FRAA:1-62TERTIARY STRUCTURE OF ERABUTOXIN B IN AQUEOUS SOLUTION ELUCIDATED BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE
1LSIA:1-66LSIII (NMR, 23 STRUCTURES)
1NXBA:1-62STRUCTURE AND FUNCTION OF SNAKE VENOM CURARIMIMETIC NEUROTOXINS
1QKDA:1-62; B:1-62ERABUTOXIN
1QKEA:1-62ERABUTOXIN
2ERAA:1-62RECOMBINANT ERABUTOXIN A, S8G MUTANT
3EBXA:1-62REFINEMENT AT 1.4 ANGSTROMS RESOLUTION OF A MODEL OF ERABUTOXIN B. TREATMENT OF ORDERED SOLVENT AND DISCRETE DISORDER
3ERAA:1-62; B:1-62RECOMBINANT ERABUTOXIN A (S8T MUTANT)
5EBXA:1-62THE CRYSTAL STRUCTURE OF ERABUTOXIN A AT 2.0 ANGSTROMS RESOLUTION
6EBXA:1-62; B:1-62STRUCTURE DETERMINATION OF A DIMERIC FORM OF ERABUTOXIN B, CRYSTALLIZED FROM THIOCYANATE SOLUTION
(-)
Bungarus candidus. Organism_taxid: 92438 (2)
2H8UA:1-65; B:1-65BUCAIN, A CARDIOTOXIN FROM THE MALAYAN KRAIT BUNGARUS CANDIDUS
2JQPA:1-65NMR STRUCTURE DETERMINATION OF BUNGATOXIN FROM BUNGARUS CANDIDUS (MALAYAN KRAIT)
(-)
Bungarus candidus. Organism_taxid: 92438. (3)
1F94A:1-63THE 0.97 RESOLUTION STRUCTURE OF BUCANDIN, A NOVEL TOXIN ISOLATED FROM THE MALAYAN KRAIT
1IJCA:1-63SOLUTION STRUCTURE OF BUCANDIN, A NEUROTOXIN FROM THE VENOM OF THE MALAYAN KRAIT
1JGKA:1-66SOLUTION STRUCTURE OF CANDOXIN
(-)
Central asian cobra (Naja oxiana) (7)
1CB9A:1-60NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULES OF CYTOTOXIN II (CARDIOTOXIN) FROM NAJA NAJA OXIANA IN AQUEOUS SOLUTION (MAJOR FORM).
1CCQA:1-60NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULES OF CYTOTOXIN II (CARDIOTOXIN) FROM NAJA NAJA OXIANA IN AQUEOUS SOLUTION (MINOR FORM).
1FFJA:1-60NMR STRUCTURE OF CARDIOTOXIN IN DPC-MICELLE
1NORA:1-61TWO-DIMENSIONAL 1H-NMR STUDY OF THE SPATIAL STRUCTURE OF NEUROTOXIN II FROM NAJA OXIANA
1NTNA:1-72THE CRYSTAL STRUCTURE OF NEUROTOXIN-I FROM NAJA NAJA OXIANA AT 1.9 ANGSTROMS RESOLUTION
1RL5A:1-60NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULE OF CYTOTOXIN I FROM NAJA OXIANA IN AQUEOUS SOLUTION (MAJOR FORM)
1ZADA:1-60STRUCTURE OF CYTOTOXIN I (CTI) FROM NAJA OXIANA IN COMPLEX WITH DPC MICELLE
(-)
Chicken (Gallus gallus) (1)
1KS6A:1-107TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN
(-)
Chinese cobra (Naja atra) (20)
1CHVS:1-60ELUCIDATION OF THE SOLUTION STRUCTURE OF CARDIOTOXIN ANALOGUE V FROM THE TAIWAN COBRA (NAJA NAJA ATRA) VENOM
1CODA:1-62SOLUTION CONFORMATION OF COBROTOXIN: A NUCLEAR MAGNETIC RESONANCE AND HYBRID DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING STUDY
1COEA:1-62SOLUTION CONFORMATION OF COBROTOXIN: A NUCLEAR MAGNETIC RESONANCE AND HYBRID DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING STUDY
1CREA:1-60CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS
1CRFA:1-60CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS
1CVOA:1-62THE SOLUTION STRUCTURE OF CARDIOTOXIN V FROM NAJA NAJA ATRA
1H0JA:1-60; B:1-60; C:1-60STRUCTURAL BASIS OF THE MEMBRANE-INDUCED CARDIOTOXIN A3 OLIGOMERIZATION
1I02A:1-60NMR STRUCTURE OF CTX A3 AT NEUTRAL PH (20 STRUCTURES)
1KBSA:1-60SOLUTION STRUCTURE OF CARDIOTOXIN IV, NMR, 1 STRUCTURE
1KBTA:1-60SOLUTION STRUCTURE OF CARDIOTOXIN IV, NMR, 12 STRUCTURES
1KXIA:1-62; B:1-62STRUCTURE OF CYTOTOXIN HOMOLOG PRECURSOR
1ONJA:1-61CRYSTAL STRUCTURE OF ATRATOXIN-B FROM CHINESE COBRA VENOM OF NAJA ATRA
1UG4A:1-60CRYSTAL STRUCTURE OF CARDIOTOXIN VI FROM TAIWAN COBRA (NAJA ATRA) VENOM
1V6PA:1-62; B:1-62CRYSTAL STRUCTURE OF COBROTOXIN
1VB0A:1-61ATOMIC RESOLUTION STRUCTURE OF ATRATOXIN-B, ONE SHORT-CHAIN NEUROTOXIN FROM NAJA ATRA
1XT3A:1-60; B:1-60STRUCTURE BASIS OF VENOM CITRATE-DEPENDENT HEPARIN SULFATE-MEDIATED CELL SURFACE RETENTION OF COBRA CARDIOTOXIN A3
2BHIA:1-60; B:1-60CRYSTAL STRUCTURE OF TAIWAN COBRA CARDIOTOXIN A3 COMPLEXED WITH SULFOGALACTOCERAMIDE
2CDXA:1-60STRUCTURE OF COBRA CARDIOTOXIN CTXI AS DERIVED FROM NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND DISTANCE GEOMETRY CALCULATIONS
2CRSA:1-60CARDIOTOXIN III FROM TAIWAN COBRA (NAJA NAJA ATRA) DETERMINATION OF STRUCTURE IN SOLUTION AND COMPARISON WITH SHORT NEUROTOXINS
2CRTA:1-60CARDIOTOXIN III FROM TAIWAN COBRA (NAJA NAJA ATRA) DETERMINATION OF STRUCTURE IN SOLUTION AND COMPARISON WITH SHORT NEUROTOXINS
(-)
Eastern green mamba (Dendroaspis angusticeps) (3)
1FASA:1-611.9 ANGSTROM RESOLUTION STRUCTURE OF FASCICULIN 1, AN ANTI-ACETYLCHOLINESTERASE TOXIN FROM GREEN MAMBA SNAKE VENOM
1FF4A:1-65X-RAY STRUCTURE OF MUSCARINIC TOXIN 2 AT 1.5 ANGSTROM RESOLUTION
1FSCA:1-61CRYSTAL STRUCTURE OF FASCICULIN 2 FROM GREEN MAMBA SNAKE VENOM: EVIDENCE FOR UNUSUAL LOOP FLEXIBILITY
(-)
Eastern jameson's mamba (Dendroaspis jamesoni kaimosae) (1)
1DRSA:1-59THREE-DIMENSIONAL STRUCTURE OF THE RGD-CONTAINING NEUROTOXIN HOMOLOGUE, DENDROASPIN
(-)
Homo sapiens. (1)
2K3GA:28-129NMR STRUCTURE ANALYSIS OF A BMP RECEPTOR
(-)
House mouse (Mus musculus) (4)
1BTEA:7-102; B:7-100CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE TYPE II ACTIVIN RECEPTOR
1KU6B:1-61FASCICULIN 2-MOUSE ACETYLCHOLINESTERASE COMPLEX
1MAHF:1-61FASCICULIN2-MOUSE ACETYLCHOLINESTERASE COMPLEX
1S4YA:5-95; C:4-98CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
(-)
Human (Homo sapiens) (26)
1B41B:1-61HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, GLYCOSYLATED PROTEIN
1CDQA:1-77STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN COMPLEMENT REGULATORY PROTEIN CD59
1CDRA:1-77STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN COMPLEMENT REGULATORY PROTEIN CD59
1CDSA:1-77STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN COMPLEMENT REGULATORY PROTEIN CD59
1ERGA:1-70THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE EXTRACELLULAR REGION OF THE COMPLEMENT REGULATORY PROTEIN, CD59, A NEW CELL SURFACE PROTEIN DOMAIN RELATED TO NEUROTOXINS
1ES7B:232-317; D:732-820COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
1F8UB:1-61CRYSTAL STRUCTURE OF MUTANT E202Q OF HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH GREEN MAMBA VENOM PEPTIDE FASCICULIN-II
1KTZB:25-130CRYSTAL STRUCTURE OF THE HUMAN TGF-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH TGF-BETA3
1LX5B:7-100CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX
1M9ZA:26-130CRYSTAL STRUCTURE OF HUMAN TGF-BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN
1PLOA:15-136TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN
1REWC:32-117; D:32-120STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
2GOOB:34-118; E:33-120; C:8-99; F:7-99TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
2H62C:34-117; D:6-98CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
2H64B:32-123; C:6-99CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
2J8BA:0-77HIGH RESOLUTION STRUCTURE OF HUMAN CD59
2OFSA:0-74CRYSTAL STRUCTURE OF HUMAN CD59
2PJYB:19-126; C:9-87STRUCTURAL BASIS FOR COOPERATIVE ASSEMBLY OF THE TGF-BETA SIGNALING COMPLEX
2QJ9C:32-117; D:32-124CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
2QJAC:32-116; D:31-123CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
2QJBC:32-116; D:32-121CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
2UWRA:0-78HIGH RESOLUTION STRUCTURE OF HUMAN CD59
2UX2A:0-77; B:0-77; C:0-77HIGH RESOLUTION STRUCTURE OF HUMAN CD59
2X8BB:1-61CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE INHIBITED BY AGED TABUN AND COMPLEXED WITH FASCICULIN-II
3EVSC:16-100CRYSTAL STRUCTURE OF THE GDF-5:BMP RECEPTOR IB COMPLEX.
3KFDF:21-126; H:21-126; E:21-128; G:20-128; J:9-84; L:9-84; I:9-85; K:9-85TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
(-)
Indian cobra (Naja naja) (1)
2CTXA:1-71THE REFINED CRYSTAL STRUCTURE OF ALPHA-COBRATOXIN FROM NAJA NAJA SIAMENSIS AT 2.4-ANGSTROMS RESOLUTION
(-)
King cobra (Ophiophagus hannah) (3)
1TXAA:1-73SOLUTION NMR STRUCTURE OF TOXIN B, A LONG NEUROTOXIN FROM THE VENOM OF THE KING COBRA, MINIMIZED AVERAGE STRUCTURE
1TXBA:1-73SOLUTION NMR STRUCTURE OF TOXIN B, A LONG NEUROTOXIN FROM THE VENOM OF THE KING COBRA, 10 STRUCTURES
3HH7A:1-65; B:1-65STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL HOMODIMERIC THREE-FINGER NEUROTOXIN FROM THE VENOM OF OPHIOPHAGUS HANNAH (KING COBRA)
(-)
Many-banded krait (Bungarus multicinctus) (24)
1BXPA:1-74SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, 20 STRUCTURES
1HAAA:1-74A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY
1HAJA:1-74A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY
1HC9A:1-74; B:1-74ALPHA-BUNGAROTOXIN COMPLEXED WITH HIGH AFFINITY PEPTIDE
1HOYA:1-74NMR STRUCTURE OF THE COMPLEX BETWEEN A-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR
1IDGA:1-74THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE
1IDHA:1-74THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE
1IDIA:1-74THE NMR SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN
1IDLA:1-74THE NMR SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN
1IK8A:1-74NMR STRUCTURE OF ALPHA-BUNGAROTOXIN
1IKCA:1-74NMR STRUCTURE OF ALPHA-BUNGAROTOXIN
1JBDA:1-74NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR
1KBAA:1-66; B:1-66CRYSTAL STRUCTURE OF KAPPA-BUNGAROTOXIN AT 2.3-ANGSTROM RESOLUTION
1KC4A:1-74NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
1KFHA:1-74SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN BY NMR SPECTROSCOPY
1KL8A:1-74NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
1L4WA:1-74NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA-BUNGAROTOXIN
1LJZA:1-74NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA-BUNGAROTOXIN
1MR6A:1-68SOLUTION STRUCTURE OF GAMMA-BUNGAROTOXIN:IMPLICATION FOR THE ROLE OF THE RESIDUES ADJACENT TO RGD IN INTEGRIN BINDING
1RGJA:1-74NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR WITH ENHANCED ACTIVITY
2ABXA:1-74; B:1-74THE CRYSTAL STRUCTURE OF ALPHA-BUNGAROTOXIN AT 2.5 ANGSTROMS RESOLUTION. RELATION TO SOLUTION STRUCTURE AND BINDING TO ACETYLCHOLINE RECEPTOR
2BTXA:1-74SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE
2NBTA:1-66; B:1-66NEURONAL BUNGAROTOXIN, NMR, 10 STRUCTURES
2QC1A:1-74CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE NICOTINIC ACETYLCHOLINE RECEPTOR 1 SUBUNIT BOUND TO ALPHA-BUNGAROTOXIN AT 1.9 A RESOLUTION
(-)
Monocled cobra (Naja kaouthia) (4)
1G6MA:1-62NMR SOLUTION STRUCTURE OF CBT2
1JE9A:1-61NMR SOLUTION STRUCTURE OF NT2
1LXGA:1-71SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (STRUCTURE ENSEMBLE)
1LXHA:1-71SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (MINIMIZED AVERAGE STRUCTURE)
(-)
Mozambique cobra (Naja mossambica) (2)
1CDTA:1-60; B:1-60CARDIOTOXIN V4/II FROM NAJA MOSSAMBICA MOSSAMBICA: THE REFINED CRYSTAL STRUCTURE
2CCXA:1-60DETERMINATION OF THE NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURE OF CARDIOTOXIN CTX IIB FROM NAJA MOSSAMBICA MOSSAMBICA
(-)
Naja siamensis. Organism_taxid: 84476 (1)
1CTXA:1-71THREE-DIMENSIONAL STRUCTURE OF THE-LONG-NEUROTOXIN FROM COBRA VENOM
(-)
Norway rat (Rattus norvegicus) (2)
1NYSA:25-117; C:25-116CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
1NYUC:26-118; A:26-118CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB
(-)
Pacific electric ray (Torpedo californica) (1)
1FSSB:1-61ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH FASCICULIN-II
(-)
Spitting cobra (Naja nigricollis) (5)
1CXNA:1-60REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE
1CXOA:1-60REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE
1IQ9A:1-61CRYSTAL STRUCTURE AT 1.8 A OF TOXIN A FROM NAJA NIGRICOLLIS VENOM
1NEAA:1-61THREE-DIMENSIONAL SOLUTION STRUCTURE OF A CURAREMIMETIC TOXIN FROM NAJA NIGRICOLLIS VENOM: A PROTON NMR AND MOLECULAR MODELING STUDY
1TGXA:1-60; B:1-60; C:1-60X-RAY STRUCTURE AT 1.55 A OF TOXIN GAMMA, A CARDIOTOXIN FROM NAJA NIGRICOLLIS VENOM. CRYSTAL PACKING REVEALS A MODEL FOR INSERTION INTO MEMBRANES
(-)
Topology: Chaperone, DNAj Protein; Chain A (2)
(-)
Homologous Superfamily: Chaperone, DNAj Protein; Chain (2)
(-)
Baker's yeast (Saccharomyces cerevisiae) (1)
1NLTA:143-208THE CRYSTAL STRUCTURE OF HSP40 YDJ1
(-)
Escherichia coli. Organism_taxid: 562. (1)
1EXKA:1-79SOLUTION STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF THE ESCHERICHIA COLI CHAPERONE PROTEIN DNAJ.
(-)
Topology: Complement Module; domain 1 (62)
(-)
Homologous Superfamily: Complement Module, domain 1 (60)
(-)
Human (Homo sapiens) (46)
1C1ZA:1-62; A:122-183; A:184-243; A:63-121; A:244-325CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)
1CKLA:1-62; B:1-62; C:1-62; D:1-62; E:1-62; F:1-62; A:63-126; B:63-126; C:63-126; D:63-126; E:63-126; F:63-126N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)
1E88A:2-43SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN
1E8BA:1-41SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN
1ELVA:342-409CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE
1FBRA:1-46; A:47-93FOURTH AND FIFTH FIBRONECTIN TYPE I MODULE PAIR
1G4FA:1-86NMR STRUCTURE OF THE FIFTH DOMAIN OF HUMAN BETA2-GLYCOPROTEIN I
1G4GA:1-86NMR STRUCTURE OF THE FIFTH DOMAIN OF HUMAN BETA2-GLYCOPROTEIN I
1GHQB:71-129; C:71-129; B:1-65; C:1-65CR2-C3D COMPLEX STRUCTURE
1GKGA:1024-1092; A:957-1023STRUCTURE DETERMINATION AND RATIONAL MUTAGENESIS REVEAL BINDING SURFACE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35)
1GKNA:897-963; A:964-1011STRUCTURE DETERMINATION AND RATIONAL MUTAGENESIS REVEAL BINDING SURFACE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35)
1GPZB:357-433; A:357-433THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R
1H03P:67-127; Q:67-127; P:5-66; Q:5-66HUMAN CD55 DOMAINS 3 & 4
1H04P:67-127; P:5-66HUMAN CD55 DOMAINS 3 & 4
1H2PP:67-127; P:5-66HUMAN CD55 DOMAINS 3 & 4
1H2QP:67-127; P:5-66HUMAN CD55 DOMAINS 3 & 4
1HCCA:1-59THREE-DIMENSIONAL STRUCTURE OF A COMPLEMENT CONTROL PROTEIN MODULE IN SOLUTION
1HFHA:65-120; A:1-64SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR MAGNETIC RESONANCE
1HFIA:1-62SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR MAGNETIC RESONANCE
1LY2A:70-128; A:0-64CRYSTAL STRUCTURE OF UNLIGANDED HUMAN CD21 SCR1-SCR2 (COMPLEMENT RECEPTOR TYPE 2)
1MD7A:358-433MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R
1MD8A:358-433MONOMERIC STRUCTURE OF THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R
1NWVA:131-189; A:61-130SOLUTION STRUCTURE OF A FUNCTIONALLY ACTIVE COMPONENT OF DECAY ACCELERATING FACTOR
1O9AA:61-109; A:17-60SOLUTION STRUCTURE OF THE COMPLEX OF 1F12F1 FROM FIBRONECTIN WITH B3 FROM FNBB FROM S. DYSGALACTIAE
1OJVA:192-254; B:192-254; A:129-191; B:129-191; B:2-64; A:1-64; A:65-128; B:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OJWA:192-253; A:129-191; B:129-191; B:3-64; A:2-64; A:65-128; B:65-128; B:192-253DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OJYA:192-253; C:192-253; B:192-254; D:192-254; A:129-191; B:129-191; C:129-191; D:129-191; A:2-64; B:2-64; D:2-64; C:1-64; A:65-128; B:65-128; C:65-128; D:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OK1A:192-254; B:192-254; A:129-191; B:129-191; B:2-64; A:1-64; A:65-128; B:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OK2A:192-254; B:192-254; A:129-191; B:129-191; B:2-64; A:1-64; A:65-128; B:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OK3A:192-254; A:129-191; B:129-191; A:2-64; B:2-64; B:192-254; A:65-128; B:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1OK9A:192-254; B:192-254; A:129-191; B:129-191; A:1-64; B:1-64; A:65-128; B:65-128DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR.
1PPQA:962-1024NMR STRUCTURE OF 16TH MODULE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35)
1Q3XB:366-433; A:362-433CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-2
1QGBA:61-109; A:17-60SOLUTION STRUCTURE OF THE N-TERMINAL F1 MODULE PAIR FROM HUMAN FIBRONECTIN
1QO6A:1-43SOLUTION STRUCTURE OF A PAIR OF MODULES FROM THE GELATIN-BINDING DOMAIN OF FIBRONECTIN
1QUBA:1-62; A:122-183; A:184-243; A:63-121; A:244-326CRYSTAL STRUCTURE OF THE GLYCOSYLATED FIVE-DOMAIN HUMAN BETA2-GLYCOPROTEIN I PURIFIED FROM BLOOD PLASMA
1TPGA:1-46F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)
1TPMA:1-50SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE
1TPNA:1-50SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE
1U5MA:9-44STRUCTURE OF A CHORDIN-LIKE CYSTEINE-RICH REPEAT (VWC MODULE) FROM COLLAGEN IIA
1UOTP:67-127; P:5-66HUMAN CD55 DOMAINS 3 & 4
2A55A:63-132SOLUTION STRUCTURE OF THE TWO N-TERMINAL CCP MODULES OF C4B-BINDING PROTEIN (C4BP) ALPHA-CHAIN.
2CG7A:62-107; A:108-151SECOND AND THIRD FIBRONECTIN TYPE I MODULE PAIR (CRYSTAL FORM II).
2KMSA:690-746COMBINED HIGH- AND LOW-RESOLUTION TECHNIQUES REVEAL COMPACT STRUCTURE IN CENTRAL PORTION OF FACTOR H DESPITE LONG INTER-MODULAR LINKERS
2KRIA:245-326STRUCTURE OF A COMPLEX BETWEEN DOMAIN V OF BETA2-GLYCOPROTEIN I AND THE FOURTH LIGAND-BINDING MODULE FROM LDLR DETERMINED WITH HADDOCK
2WIIC:127-190COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4
(-)
Human adenovirus 11p. Organism_taxid: 343462. Strain: slobiski. (1)
2O39C:1-62; D:1-62; C:63-126; D:63-126HUMAN ADENOVIRUS TYPE 11 KNOB IN COMPLEX WITH DOMAINS SCR1 AND SCR2 OF CD46 (MEMBRANE COFACTOR PROTEIN, MCP)
(-)
Human adenovirus 21. Organism_taxid: 32608. Strain: 2145. (1)
3L89M:1-62; N:1-62; W:1-62; X:1-62; T:63-126; Q:63-126; W:63-126; M:63-126; N:63-126; O:63-126; P:63-126; R:63-126; O:1-62; S:63-126; U:63-126; V:63-126; X:63-126; P:1-62; Q:1-62; R:1-62; S:1-62; T:1-62; U:1-62; V:1-62HUMAN ADENOVIRUS TYPE 21 KNOB IN COMPLEX WITH DOMAINS SCR1 AND SCR2 OF CD46 (MEMBRANE COFACTOR PROTEIN, MCP)
(-)
Measles virus strain edmonston (1)
3INBC:1-62; D:1-62; C:63-126; D:63-126STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO THE CD46 RECEPTOR
(-)
Norway rat (Rattus norvegicus) (2)
1SRZA:92-159SOLUTION STRUCTURE OF THE SECOND COMPLEMENT CONTROL PROTEIN (CCP) MODULE OF THE GABA(B)R1A RECEPTOR, PRO-119 TRANS CONFORMER
1SS2A:92-159SOLUTION STRUCTURE OF THE SECOND COMPLEMENT CONTROL PROTEIN (CCP) MODULE OF THE GABA(B)R1A RECEPTOR, PRO-119 CIS CONFORMER
(-)
Rhodopseudomonas palustris cga009. Organism_taxid: 258594. Strain: cga009. (1)
2JRAA:26-67; B:26-67A NOVEL DOMAIN-SWAPPED SOLUTION NMR STRUCTURE OF PROTEIN RPA2121 FROM RHODOPSEUDOMONAS PALUSTRIS. NORTHEAST STRUCTURAL GENOMICS TARGET RPT6
(-)
Vaccinia virus wr. Organism_taxid: 10254. Strain: wr. (1)
1RIDA:66-125; B:66-125; A:185-234; B:185-234; A:127-184; B:127-184; A:1-65; B:1-65VACCINIA COMPLEMENT PROTEIN IN COMPLEX WITH HEPARIN
(-)
Vaccinia virus. Organism_taxid: 10245. (3)
1VVCA:59-118; A:1-58C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE
1VVDA:59-118; A:1-58C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES
1VVEA:59-118; A:1-58C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES
(-)
Vaccinia virus. Organism_taxid: 10245. (2)
1G40A:66-125; B:66-125; B:127-184; A:1-65; B:1-65; A:185-234; B:185-234; A:127-184CRYSTAL STRUCTURE OF A COMPLEMENT PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS
1G44A:66-125; A:127-184; B:127-184; C:127-185; C:1-65; B:1-65; A:1-65; C:187-230; B:66-125; C:66-125; A:185-243; B:185-232CRYSTAL STRUCTURE OF A COMPLEMENT CONTROL PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS
(-)
Vaccinia virus. Organism_taxid: 10245. Strain: western reserve. (1)
1Y8EB:66-126; A:66-125; B:185-244; A:185-234; A:127-184; B:127-184; B:2-65; A:1-65VCP:SURAMIN COMPLEX
(-)
Vaccinia virus. Organism_taxid: 10249. Strain: copenhagen. (1)
1E5GA:7-68; A:69-126SOLUTION STRUCTURE OF CENTRAL CP MODULE PAIR OF A POX VIRUS COMPLEMENT INHIBITOR
(-)
Homologous Superfamily: gspk-gspi-gspj complex like domains (1)
(-)
Escherichia coli. Organism_taxid: 562. Strain: h10407. (1)
3CI0J:143-192THE CRYSTAL STRUCTURE OF THE GSPK-GSPI-GSPJ COMPLEX FROM ENTEROTOXIGENIC ESCHERICHIA COLI TYPE 2 SECRETION SYSTEM
(-)
Homologous Superfamily: Ta1353-like (1)
(-)
Thermoplasma acidophilum. Organism_taxid: 2303. (1)
1RLHA:-15-5,A:107-135STRUCTURE OF A CONSERVED PROTEIN FROM THERMOPLASMA ACIDOPHILUM
(-)
Topology: Cysteine Protease (Bromelain) Inhibitor, subunit H (20)
(-)
Homologous Superfamily: Cysteine Protease (Bromelain) Inhibitor, subunit H (20)
(-)
Cattle (Bos taurus) (3)
1D6RI:6-63CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2.3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY
2G81I:17-72CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM VIGNA UNGUICULATA SEEDS IN COMPLEX WITH BETA-TRYPSIN AT 1.55 ANGSTRONS RESOLUTION
2ILNI:8-60CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM SNAIL MEDIC SEEDS IN COMPLEX WITH BOVINE TRYPSIN
(-)
Cow (Bos taurus) (1)
1TABI:12-73STRUCTURE OF THE TRYPSIN-BINDING DOMAIN OF BOWMAN-BIRK TYPE PROTEASE INHIBITOR AND ITS INTERACTION WITH TRYPSIN
(-)
Cowpea (Vigna unguiculata) (1)
2R33B:17-73; A:17-73CRYSTAL STRUCTURE OF A BOWMAN-BIRK INHIBITOR FROM VIGNA UNGUICULATA SEEDS
(-)
Hordeum vulgare. Organism_taxid: 4513 (1)
1C2AA:4-63; A:64-123CRYSTAL STRUCTURE OF BARLEY BBI
(-)
Hordeum vulgare. Organism_taxid: 4513. (1)
2FJ8A:4-63; A:64-123HIGH RESOLUTION STRUCTURE OF BARLEY BOWMAN-BIRK INHIBITOR
(-)
Lentil (Lens culinaris) (1)
2AIHA:1-671H-NMR SOLUTION STRUCTURE OF A TRYPSIN/CHYMOTRYPSIN BOWMAN-BIRK INHIBITOR FROM LENS CULINARIS.
(-)
Lima bean (Phaseolus lunatus) (1)
1H34A:16-72CRYSTAL STRUCTURE OF LIMA BEAN TRYPSIN INHIBITOR
(-)
Medicago scutellata. Organism_taxid: 36901. (1)
1MVZA:1-62NMR SOLUTION STRUCTURE OF A BOWMAN BIRK INHIBITOR ISOLATED FROM SNAIL MEDIC SEEDS (MEDICAGO SCUTELLATA)
(-)
Pea (Pisum sativum) (1)
1PBIA:5-73; B:5-73CRYSTAL STRUCTURE OF A BOWMAN-BIRK INHIBITOR FROM PEA SEEDS
(-)
Pig (Sus scrofa) (1)
1TX6J:5-63; I:5-63; J:64-125; I:64-125TRYPSIN:BBI COMPLEX
(-)
Pineapple (Ananas comosus) (2)
1BI6H:1-41NMR STRUCTURE OF BROMELAIN INHIBITOR VI FROM PINEAPPLE STEM
2BI6H:1-41NMR STUDY OF BROMELAIN INHIBITOR VI FROM PINEAPPLE STEM
(-)
Soybean (Glycine max) (4)
1BBIA:1-71THREE-DIMENSIONAL STRUCTURE OF SOYBEAN TRYPSIN(SLASH)CHYMOTRYPSIN BOWMAN-BIRK INHIBITOR IN SOLUTION
1K9BA:6-63CRYSTAL STRUCTURE OF THE BIFUNCTIONAL SOYBEAN BOWMAN-BIRK INHIBITOR AT 0.28 NM RESOLUTION. STRUCTURAL PECULIARITIES IN A FOLDED PROTEIN CONFORMATION
1PI2A:3-63REACTIVE SITES OF AN ANTICARCINOGENIC BOWMAN-BIRK PROTEINASE INHIBITOR ARE SIMILAR TO OTHER TRYPSIN INHIBITORS
2BBIA:1-71THREE-DIMENSIONAL STRUCTURE OF SOYBEAN TRYPSIN(SLASH)CHYMOTRYPSIN BOWMAN-BIRK INHIBITOR IN SOLUTION
(-)
Topology: Cysteine Rich Protein (18)
(-)
Homologous Superfamily: Cysteine Rich Protein (18)
(-)
Black rat (Rattus rattus) (1)
1IMLA:1-76CYSTEINE RICH INTESTINAL PROTEIN, NMR, 48 STRUCTURES
(-)
Chicken (Gallus gallus) (2)
1B8TA:1-69; A:113-175SOLUTION STRUCTURE OF THE CHICKEN CRP1
1CTLA:1-85STRUCTURE OF THE CARBOXY-TERMINAL LIM DOMAIN FROM THE CYSTEINE RICH PROTEIN CRP
(-)
House mouse (Mus musculus) (4)
1J2OA:1-114STRUCTURE OF FLIN2, A COMPLEX CONTAINING THE N-TERMINAL LIM DOMAIN OF LMO2 AND LDB1-LID
1M3VA:1-122FLIN4: FUSION OF THE LIM BINDING DOMAIN OF LDB1 AND THE N-TERMINAL LIM DOMAIN OF LMO4
1RUTX:19-82,X:314-327; X:83-313COMPLEX OF LMO4 LIM DOMAINS 1 AND 2 WITH THE LDB1 LID DOMAIN
2DFYC:19-82,C:314-327; X:19-82,X:314-327; C:83-313; X:83-313CRYSTAL STRUCTURE OF A CYCLIZED PROTEIN FUSION OF LMO4 LIM DOMAINS 1 AND 2 WITH THE LIM INTERACTING DOMAIN OF LDB1
(-)
Human (Homo sapiens) (7)
1G47A:1-701ST LIM DOMAIN OF PINCH PROTEIN
1NYPA:1-664TH LIM DOMAIN OF PINCH PROTEIN
1U5SB:72-137NMR STRUCTURE OF THE COMPLEX BETWEEN NCK-2 SH3 DOMAIN AND PINCH-1 LIM4 DOMAIN
1X6AA:15-76SOLUTION STRUCTURES OF THE SECOND LIM DOMAIN OF HUMAN LIM-KINASE 2 (LIMK2)
2CU8A:1-76SOLUTION STRUCTURE OF THE LIM DOMAIN OF HUMAN CYSTEINE-RICH PROTEIN 2
2O10A:7-66SOLUTION STRUCTURE OF THE N-TERMINAL LIM DOMAIN OF MLP/CRP3
2O13A:119-176SOLUTION STRUCTURE OF THE C-TERMINAL LIM DOMAIN OF MLP/CRP3
(-)
Japanese quail (Coturnix japonica) (4)
1A7IA:8-67AMINO-TERMINAL LIM DOMAIN FROM QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE
1CXXA:117-175MUTANT R122A OF QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED STRUCTURE
1IBIA:117-175QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, 15 MINIMIZED MODEL STRUCTURES
1QLIA:117-175QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE
(-)
Topology: Cystine Knot Cytokines, subunit B (102)
(-)
Homologous Superfamily: Cystine-knot cytokines (102)
(-)
Daboia russellii russellii. Organism_taxid: 31159. Strain: russellii. (1)
1WQ9A:1-96; B:2-96CRYSTAL STRUCTURE OF VR-1, A VEGF-F FROM A SNAKE VENOM
(-)
House mouse (Mus musculus) (6)
1BETA:10-116NEW PROTEIN FOLD REVEALED BY A 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NERVE GROWTH FACTOR
1BJ1V:14-107; W:14-107VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1BTGA:10-117; B:10-118; C:10-118CRYSTAL STRUCTURE OF BETA NERVE GROWTH FACTOR AT 2.5 A RESOLUTION IN C2 SPACE GROUP WITH ZN IONS BOUND
1S4YD:4-116; B:1-116CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
1SGFB:10-118; Y:8-118CRYSTAL STRUCTURE OF 7S NGF: A COMPLEX OF NERVE GROWTH FACTOR WITH FOUR BINDING PROTEINS (SERINE PROTEINASES)
1TZIV:13-109CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
(-)
Human (Homo sapiens) (84)
1B8KA:11-112NEUROTROPHIN-3 FROM HUMAN
1B8MA:8-116; B:12-130BRAIN DERIVED NEUROTROPHIC FACTOR, NEUROTROPHIN-4
1B98A:13-127; M:11-126NEUROTROPHIN 4 (HOMODIMER)
1BMPA:36-139BONE MORPHOGENETIC PROTEIN-7
1BNDB:8-116; A:8-116STRUCTURE OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR(SLASH)NEUROTROPHIN 3 HETERODIMER
1CZ8V:14-107; W:14-107VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1DZ7A:1-92SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITHOUT CARBOHYDRATE RESIDUES]
1E9JA:1-92SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [INCLUDING A SINGLE GLCNAC RESIDUE AT ASN52 AND ASN78]
1ES7A:11-114; C:511-614COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
1FL7D:3-108; B:3-109; C:5-92; A:5-90HUMAN FOLLICLE STIMULATING HORMONE
1FLTW:12-109; V:13-107VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
1FZVA:18-117; B:18-117THE CRYSTAL STRUCTURE OF HUMAN PLACENTA GROWTH FACTOR-1 (PLGF-1), AN ANGIOGENIC PROTEIN AT 2.0A RESOLUTION
1HCFA:1-127; B:5-128CRYSTAL STRUCTURE OF TRKB-D5 BOUND TO NEUROTROPHIN-4/5
1HCNB:2-111; A:5-89STRUCTURE OF HUMAN CHORIONIC GONADOTROPIN AT 2.6 ANGSTROMS RESOLUTION FROM MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN
1HD4A:1-92SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITH DIANTENNARY GLYCAN AT ASN78]
1HRPB:2-111; A:4-89CRYSTAL STRUCTURE OF HUMAN CHORIONIC GONADOTROPIN
1JPYX:9-128; Y:6-130; A:8-128; B:8-128CRYSTAL STRUCTURE OF IL-17F
1KATV:11-109; W:11-109SOLUTION STRUCTURE OF A PHAGE-DERIVED PEPTIDE ANTAGONIST IN COMPLEX WITH VASCULAR ENDOTHELIAL GROWTH FACTOR
1KLAA:1-112; B:1-112SOLUTION STRUCTURE OF TGF-B1, NMR, MODELS 1-17 OF 33 STRUCTURES
1KLCA:1-112; B:1-112SOLUTION STRUCTURE OF TGF-B1, NMR, MINIMIZED AVERAGE STRUCTURE
1KLDA:1-112; B:1-112SOLUTION STRUCTURE OF TGF-B1, NMR, MODELS 18-33 OF 33 STRUCTURES
1KTZA:13-112CRYSTAL STRUCTURE OF THE HUMAN TGF-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH TGF-BETA3
1LX5A:36-139CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX
1LXIA:36-139REFINEMENT OF BMP7 CRYSTAL STRUCTURE
1M4UL:28-139; A:38-88,A:155-232CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN
1MJVA:13-108; B:13-108DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C51A AND C60A)
1MKGA:14-107; B:14-107; C:14-107; D:14-107DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C57A AND C102A)
1MKKB:13-106; A:14-106DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C61A AND C104A)
1NT3A:8-115HUMAN NEUROTROPHIN-3
1PDGA:9-104; C:7-102; B:7-100CRYSTAL STRUCTURE OF HUMAN PLATELET-DERIVED GROWTH FACTOR BB
1QFWB:2-112; A:6-92TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT
1QTYS:13-108; R:13-107; V:13-107; W:13-107VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
1REUA:12-114STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN 2 MUTANT L51P
1REWA:12-114; B:12-114STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
1RV6W:21-115; V:22-115CRYSTAL STRUCTURE OF PLGF IN COMPLEX WITH DOMAIN 2 OF VEGFR1
1SG1B:9-116; A:11-115CRYSTAL STRUCTURE OF THE RECEPTOR-LIGAND COMPLEX BETWEEN NERVE GROWTH FACTOR AND THE COMMON NEUROTROPHIN RECEPTOR P75
1TFGA:1-112AN UNUSUAL FEATURE REVEALED BY THE CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF HUMAN TRANSFORMING GROWTH FACTOR-BETA2
1TGJA:1-112HUMAN TRANSFORMING GROWTH FACTOR-BETA 3, CRYSTALLIZED FROM DIOXANE
1TGKA:1-112HUMAN TRANSFORMING GROWTH FACTOR BETA 3, CRYSTALLIZED FROM PEG 4000
1TZHV:14-107; W:14-107CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
1VPFA:14-107; B:14-107; C:14-107; D:14-107STRUCTURE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR
1VPPV:13-108; W:13-108COMPLEX BETWEEN VEGF AND A RECEPTOR BLOCKING PEPTIDE
1WAQA:17-120CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF-5)
1WWWV:2-115; W:2-116NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR
1XWDB:3-107; E:3-107; A:3-92; D:6-92CRYSTAL STRUCTURE OF HUMAN FOLLICLE STIMULATING HORMONE COMPLEXED WITH ITS RECEPTOR
1ZKZA:4-110CRYSTAL STRUCTURE OF BMP9
2ARPA:1-116ACTIVIN A IN COMPLEX WITH FS12 FRAGMENT OF FOLLISTATIN
2ARVB:1-116; A:1-116STRUCTURE OF HUMAN ACTIVIN A
2ASKA:13-113; B:13-113STRUCTURE OF HUMAN ARTEMIN
2B0UA:1-116; B:1-116THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX
2BHKA:15-119CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF5)
2C7WA:13-108; B:13-108CRYSTAL STRUCTURE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR-B: IDENTIFICATION OF AMINO ACIDS IMPORTANT FOR ANGIOGENINC ACTIVITY
2FJGV:14-108; W:14-107STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHV:12-109; W:13-109STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2GH0C:120-219; D:121-219GROWTH FACTOR/RECEPTOR COMPLEX
2GOOA:12-114; D:11-114TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
2GYRA:4-100; B:4-100; C:4-100; D:4-100; E:4-100; F:4-100CRYSTAL STRUCTURE OF HUMAN ARTEMIN
2GYZA:4-100CRYSTAL STRUCTURE OF HUMAN ARTEMIN
2H62B:12-114; A:11-114CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
2H64A:10-114CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
2IFGE:2-115; F:2-116STRUCTURE OF THE EXTRACELLULAR SEGMENT OF HUMAN TRKA IN COMPLEX WITH NERVE GROWTH FACTOR
2P6AA:1-116; B:1-116THE STRUCTURE OF THE ACTIVIN:FOLLISTATIN 315 COMPLEX
2PJYA:1-112STRUCTURAL BASIS FOR COOPERATIVE ASSEMBLY OF THE TGF-BETA SIGNALING COMPLEX
2QCQA:4-110; B:3-110CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-3 (BMP-3)
2QCWA:29-132; B:29-132CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
2QJ9B:12-114; A:11-114CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
2QJAA:11-114; B:11-114CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
2QJBA:12-114; B:11-114CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
2QR0D:13-109; J:13-109; P:13-109; V:13-109; C:13-107; I:13-107; O:13-107; U:13-107STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2R52A:28-132; B:28-132CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
2R53A:26-132; B:26-132CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 VARIANT B2 (B2-BMP-6)
2TGIA:1-112CRYSTAL STRUCTURE OF TRANSFORMING GROWTH FACTOR-BETA2: AN UNUSUAL FOLD FOR THE SUPERFAMILY
2VPFA:13-109; G:13-107; H:14-107; C:14-106; B:13-108; E:13-108; F:13-108; D:13-107VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION
2VWEA:11-108; B:11-108CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2X1WD:117-215; A:116-213; B:117-214; C:119-215CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2
2X1XE:113-215CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM
2XACA:10-108; B:11-108STRUCTURAL INSIGHTS INTO THE BINDING OF VEGF-B BY VEGFR-1D2: RECOGNITION AND SPECIFICITY
3B4VE:1-116; A:1-116; B:1-116; F:1-116X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
3BDYV:14-108DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BK3A:11-114; B:11-114CRYSTAL STRUCTURE OF THE COMPLEX OF BMP-2 AND THE FIRST VON WILLEBRAND DOMAIN TYPE C OF CROSSVEINLESS-2
3BMPA:9-114HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2)
3BUKA:5-115; B:5-115CRYSTAL STRUCTURE OF THE NEUROTROPHIN-3 AND P75NTR SYMMETRICAL COMPLEX
3EVSB:17-120CRYSTAL STRUCTURE OF THE GDF-5:BMP RECEPTOR IB COMPLEX.
3KFDA:1-112; B:1-112; C:1-112; D:1-112TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
(-)
Mouse (Mus musculus) (2)
3HH2A:1-109; B:1-109CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN 288 COMPLEX
3IJ2A:8-117; B:8-117LIGAND-RECEPTOR STRUCTURE
(-)
Mus musculus. Organism_taxid: 10090. (1)
3EO1C:1-112; F:1-112; I:1-112; L:1-112STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
(-)
Norway rat (Rattus norvegicus) (4)
1AGQB:38-135; D:41-135; A:39-135; C:41-135GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
1NYSB:2-116; D:10-116CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
1NYUB:2-116; D:11-116CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB
2V5EB:34-134THE STRUCTURE OF THE GDNF:CORECEPTOR COMPLEX: INSIGHTS INTO RET SIGNALLING AND HEPARIN BINDING.
(-)
Orf virus (strain nz2). Organism_taxid: 10259. Strain: nz2. (1)
2GNNB:13-107; D:14-106; A:11-109; C:11-110CRYSTAL STRUCTURE OF THE ORF VIRUS NZ2 VARIANT OF VEGF-E
(-)
Rat (Rattus norvegicus) (1)
3FUBD:32-134; B:40-134CRYSTAL STRUCTURE OF GDNF-GFRALPHA1 COMPLEX
(-)
Tachypleus tridentatus. Organism_taxid: 6853 (1)
1AOCA:1-175; B:1-175JAPANESE HORSESHOE CRAB COAGULOGEN
(-)
Vipera aspis aspis. Organism_taxid: 194601. Strain: aspis. (1)
1WQ8A:2-100CRYSTAL STRUCTURE OF VAMMIN, A VEGF-F FROM A SNAKE VENOM
(-)
Topology: Cytochrome Bc1 Complex; Chain I (29)
(-)
Homologous Superfamily: Cytochrome Bc1 Complex; Chain I (29)
(-)
Cattle (Bos taurus) (17)
1BE3I:46-78CYTOCHROME BC1 COMPLEX FROM BOVINE
1BGYI:46-78; U:46-78CYTOCHROME BC1 COMPLEX FROM BOVINE
1L0LI:1-57STRUCTURE OF BOVINE MITOCHONDRIAL CYTOCHROME BC1 COMPLEX WITH A BOUND FUNGICIDE FAMOXADONE
1L0NI:1-57NATIVE STRUCTURE OF BOVINE MITOCHONDRIAL CYTOCHROME BC1 COMPLEX
1NTKI:1-57CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 IN COMPLEX WITH ANTIMYCIN A1
1NTMI:1-57CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEX AT 2.4 ANGSTROM
1NTZI:1-57CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEX BOUND WITH UBIQUINONE
1NU1I:1-57CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEXED WITH 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE (NQNO)
1PP9I:32-78; V:32-78BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND
1PPJI:32-78; V:32-78BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN AND ANTIMYCIN
1SQBI:1-57CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH AZOXYSTROBIN
1SQPI:1-57CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH MYXOTHIAZOL
1SQQI:1-57CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH METHOXY ACRYLATE STILBENE (MOAS)
1SQVI:1-57CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH UHDBT
1SQXI:1-57CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH STIGMATELLIN A
2A06I:32-78; V:32-78BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND
2FYUI:1-57CRYSTAL STRUCTURE OF BOVINE HEART MITOCHONDRIAL BC1 WITH JG144 INHIBITOR
(-)
Chicken (Gallus gallus) (12)
3CWBV:20-77; I:20-77CHICKEN CYTOCHROME BC1 COMPLEX INHIBITED BY AN IODINATED ANALOGUE OF THE POLYKETIDE CROCACIN-D
3H1HI:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN
3H1II:28-77; V:28-77STIGMATELLIN AND ANTIMYCIN BOUND CYTOCHROME BC1 COMPLEX FROM CHICKEN
3H1JI:28-77; V:28-77STIGMATELLIN-BOUND CYTOCHROME BC1 COMPLEX FROM CHICKEN
3H1KI:28-77; V:28-77CHICKEN CYTOCHROME BC1 COMPLEX WITH ZN++ AND AN IODINATED DERIVATIVE OF KRESOXIM-METHYL BOUND
3H1LI:28-77; V:28-77CHICKEN CYTOCHROME BC1 COMPLEX WITH ASCOCHLORIN BOUND AT QO AND QI SITES
3L70I:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN WITH TRIFLOXYSTROBIN BOUND
3L71I:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN WITH AZOXYSTROBIN BOUND
3L72I:28-77; V:28-77CHICKEN CYTOCHROME BC1 COMPLEX WITH KRESOXYM-I-DIMETHYL BOUND
3L73I:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN WITH TRIAZOLONE INHIBITOR
3L74I:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN WITH FAMOXADONE BOUND
3L75I:28-77; V:28-77CYTOCHROME BC1 COMPLEX FROM CHICKEN WITH FENAMIDONE BOUND
(-)
Topology: Dihydroorotate dehydrogenase B (pyrk subunit); domain 3 (3)
(-)
Homologous Superfamily: Dihydroorotate dehydrogenase b (pyrk subunit), domain 3 (3)
(-)
Lactococcus lactis. Organism_taxid: 1358. (3)
1EP1B:221-262CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B
1EP2B:221-262CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B COMPLEXED WITH OROTATE
1EP3B:221-262CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B. DATA COLLECTED UNDER CRYOGENIC CONDITIONS.
(-)
Topology: heat- and protease-stable fragment of the bacteriophage t4 short fibre, domain 1 (1)
(-)
Homologous Superfamily: heat- and protease-stable fragment of the bacteriophage t4 short fibre, domain 1 (1)
(-)
Bacteriophage t4. Organism_taxid: 10665. Strain: t4d. (1)
1H6WA:246-286CRYSTAL STRUCTURE OF A HEAT- AND PROTEASE-STABLE FRAGMENT OF THE BACTERIOPHAGE T4 SHORT FIBRE
(-)
Topology: Hemagglutinin; Chain A, domain 2 (27)
(-)
Homologous Superfamily: Hemagglutinin Chain A, Domain 2 (27)
(-)
A/viet nam/1203/2004(h5n1) (Influenza a virus (a/viet nam/1203/2004(h5n1))) (1)
3GBMC:9-56,C:273-324; A:8-56,A:273-324CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
(-)
House mouse (Mus musculus) (3)
2VIRC:43-56,C:273-309INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VISC:43-56,C:273-309INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VITC:43-56,C:273-309INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
(-)
Influenza a virus (a/mallard/alberta/35/1976(h1n1)). Organism_taxid:352520. (1)
2WRHH:5-46,H:277-327; J:5-46,J:277-327; L:5-46,L:277-327STRUCTURE OF H1 DUCK ALBERT HEMAGGLUTININ WITH HUMAN RECEPTOR
(-)
Influenza a virus (a/brevig mission/1/1918(h1n1)). Organism_taxid: 88776. (1)
2WRGH:5-46,H:277-328; J:5-46,J:277-328; L:5-46,L:277-328STRUCTURE OF H1 1918 HEMAGGLUTININ WITH HUMAN RECEPTOR
(-)
Influenza a virus (a/puerto rico/8/34(h1n1)). Organism_taxid: 211044.Strain: a-puerto rico-8-34. (3)
1RU7A:5-45,A:277-327; C:5-45,C:277-327; E:5-45,E:277-327; G:5-45,G:277-327; I:5-45,I:277-327; K:5-45,K:277-3271934 HUMAN H1 HEMAGGLUTININ
1RVXA:5-46,A:277-327; C:5-46,C:277-327; E:5-46,E:277-327; G:5-46,G:277-327; I:5-46,I:277-327; K:5-46,K:277-3271934 H1 HEMAGGLUTININ IN COMPLEX WITH LSTA
1RVZA:5-46,A:277-327; I:5-46,I:277-327; K:5-46,K:277-327; C:5-46,C:277-327; E:5-46,E:277-327; G:5-46,G:277-3271934 H1 HEMAGGLUTININ IN COMPLEX WITH LSTC
(-)
Influenza a virus (a/south carolina/1/18 (h1n1)). Organism_taxid: 59375. Strain: a-south carolina-1-18 (h1n1). (1)
1RUZH:5-46,H:277-327; J:5-46,J:277-327; L:5-46,L:277-3271918 H1 HEMAGGLUTININ
(-)
Influenza a virus (a/swine/hong kong/9/98(h9n2)). Organism_taxid: 145307. Strain: a/swine/hong kong/9/98. (3)
1JSDA:2-47,A:264-317CRYSTAL STRUCTURE OF SWINE H9 HAEMAGGLUTININ
1JSHA:1-47,A:264-317CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTOR ANALOG
1JSIA:1-47,A:264-317CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG
(-)
Influenza a virus (a/swine/iowa/15/30(h1n1)). Organism_taxid: 260809.Strain: a-swine-iowa-15-30 (h1n1). (1)
1RUYH:5-46,H:277-327; J:5-46,J:277-327; L:5-46,L:277-3271930 SWINE H1 HEMAGGLUTININ
(-)
Influenza a virus (a/viet nam/1203/2004(h5n1)). Organism_taxid: 284218. Strain: a/vietnam/1203/2004. (1)
2FK0A:10-56,A:273-324; C:10-56,C:273-324; E:10-56,E:273-324; G:10-56,G:273-324; I:10-56,I:273-324; K:10-56,K:273-324; M:10-56,M:273-324; O:10-56,O:273-324; Q:10-56,Q:273-324CRYSTAL STRUCTURE OF A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
(-)
Influenza a virus (a/x-31(h3n2)). Organism_taxid: 132504. Strain: x31. (2)
1QFUA:9-56,A:273-325INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VIUA:29-56,A:273-328INFLUENZA VIRUS HEMAGGLUTININ
(-)
Influenza a virus (strain a/south carolina/1/1918 h1n1) (Influenza a virus (a/brevig mission/1/1918(h1n1))) (1)
3GBNA:7-51,A:276-326CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ
(-)
Influenza a virus. Organism_taxid: 11320. (1)
1RD8A:10-51,A:276-329; C:10-51,C:276-329; E:10-51,E:276-329CRYSTAL STRUCTURE OF THE 1918 HUMAN H1 HEMAGGLUTININ PRECURSOR (HA0)
(-)
Influenza a virus. Organism_taxid: 11320. Strain: a-swine-iowa-30. (1)
1RV0H:5-46,H:277-327; J:5-46,J:277-327; L:5-46,L:277-3271930 SWINE H1 HEMAGGLUTININ COMPLEXED WITH LSTA
(-)
Influenza a virus. Organism_taxid: 11320. Strain: a-turkey-italy-02. (1)
1TI8A:13-56,A:273-325H7 HAEMAGGLUTININ
(-)
Influenza a virus. Organism_taxid: 11320. Strain: a/duck/singapore/3/97. (3)
1JSMA:1-47,A:270-321STRUCTURE OF H5 AVIAN HAEMAGGLUTININ
1JSNA:1-47,A:270-321STRUCTURE OF AVIAN H5 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTRO ANALOG
1JSOA:1-47,A:270-321STRUCTURE OF AVIAN H5 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG
(-)
Influenza a virus. Organism_taxid: 11320. Strain: h5n1 (vn1194). (1)
2IBXA:5-51,A:274-325; C:5-51,C:274-325; E:5-51,E:274-325INFLUENZA VIRUS (VN1194) H5 HA
(-)
Influenza a virus. Organism_taxid: 284218. Strain: h5n1. (1)
3FKUA:4-51,A:274-326; C:4-51,C:274-326; E:4-51,E:274-326; G:4-51,G:274-326; I:4-51,I:274-326; K:4-51,K:274-326CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10
(-)
Unidentified influenza virus. Organism_taxid: 11309. Strain: a/swine/iowa/15/30. (1)
1RVTH:5-46,H:277-327; J:5-46,J:277-327; L:5-46,L:277-3271930 H1 HEMAGGLUTININ IN COMPLEX WITH LSTC
(-)
Topology: Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A domain 2 (15)
(-)
Homologous Superfamily: Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A, domain 2 (15)
(-)
House mouse (Mus musculus) (1)
2DTG  [entry was replaced by entry 4ZXB without any CATH domain information]
(-)
Human (Homo sapiens) (13)
1IGRA:224-299TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3)
1IVOA:187-309; B:187-309CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTH FACTOR AND RECEPTOR EXTRACELLULAR DOMAINS.
1M6BA:199-308; A:481-580; B:514-611; B:192-309STRUCTURE OF THE HER3 (ERBB3) EXTRACELLULAR DOMAIN
1MOXA:187-309; B:187-309CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA
1N8ZC:193-316; C:485-607CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
1NQLA:191-309; A:482-614STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMAL GROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH) COMPLEX WITH EGF.
1S78B:203-312; A:204-315; B:492-577; A:511-564INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX
1YY9A:198-308; A:481-614STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC-C225
2A91A:195-317CRYSTAL STRUCTURE OF ERBB2 DOMAINS 1-3
2AHXA:195-305; B:195-305; B:477-614; A:477-616CRYSTAL STRUCTURE OF ERBB4/HER4 EXTRACELLULAR DOMAIN
2HR7A:192-309; B:241-309INSULIN RECEPTOR (DOMAINS 1-3)
3B2VA:480-558; A:239-304; A:559-613CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3BE1A:193-316; A:485-607DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
(-)
Norway rat (Rattus norvegicus) (1)
1N8YC:194-317; C:486-608CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF RAT HER2
(-)
Topology: Laminin (270)
(-)
Homologous Superfamily: Alliin lyase; domain 1 (3)
(-)
Garlic (Allium sativum) (3)
1LK9A:2-100; B:2-100THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC
2HORA:1-100CRYSTAL STRUCTURE OF ALLIINASE FROM GARLIC- APO FORM
2HOXA:1-100; B:1-100; C:1-100; D:1-100ALLIINASE FROM ALLIUM SATIVUM (GARLIC)
(-)
Homologous Superfamily: Laminin (263)
(-)
Bos taurus. Organism_taxid: 9913 (1)
1CCFA:45-86HOW AN EPIDERMAL GROWTH FACTOR (EGF)-LIKE DOMAIN BINDS CALCIUM-HIGH RESOLUTION NMR STRUCTURE OF THE CALCIUM FORM OF THE NH2-TERMINAL EGF-LIKE DOMAIN IN COAGULATION FACTOR X
(-)
Cattle (Bos taurus) (4)
1APOA:45-86THREE-DIMENSIONAL STRUCTURE OF THE APO FORM OF THE N-TERMINAL EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X AS DETERMINED BY NMR SPECTROSCOPY AND SIMULATED FOLDING
1KIGL:389-439BOVINE FACTOR XA
1WHEA:47-86COAGULATION FACTOR, NMR, 20 STRUCTURES
1WHFA:47-86COAGULATION FACTOR, NMR, 15 STRUCTURES
(-)
Corynebacterium diphtheriae. Organism_taxid: 1717. Variant: lysogenized by the corynephage beta. (1)
1XDTR:107-147COMPLEX OF DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR
(-)
Dog hookworm (Ancylostoma caninum) (1)
1COUA:1-85ANTICOAGULANT PROTEIN FROM THE NEMATODE ANCYLOSTOMA CANINUM
(-)
Domestic sheep,lambs,wild sheep (Ovis aries) (1)
3KK6A:33-73; B:33-73CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH CELECOXIB
(-)
Fire-bellied toad (Bombina bombina) (1)
1HX2A:1-60SOLUTION STRUCTURE OF BSTI, A TRYPSIN INHIBITOR FROM BOMBINA BOMBINA.
(-)
Fruit fly (Drosophila melanogaster) (2)
3C9AC:50-97; D:50-97HIGH RESOLUTION CRYSTAL STRUCTURE OF ARGOS BOUND TO THE EGF DOMAIN OF SPITZ
3CA7A:48-97HIGH RESOLUTION CRYSTAL STRUCTURE OF THE EGF DOMAIN OF SPITZ
(-)
Homo sapiens. Organism_taxid: 9606. Homo sapiens. Organism_taxid: 9606. (1)
3F6UL:94-146; L:49-93CRYSTAL STRUCTURE OF HUMAN ACTIVATED PROTEIN C (APC) COMPLEXED WITH PPACK
(-)
Honey bee (Apis mellifera) (1)
1CCVA:1-56NMR SOLUTION STRUCTURE OF APIS MELLIFERA CHYMOTRYPSIN INHIBITOR (AMCI).
(-)
House mouse (Mus musculus) (18)
1A3PA:4-48ROLE OF THE 6-20 DISULFIDE BRIDGE IN THE STRUCTURE AND ACTIVITY OF EPIDERMAL GROWTH FACTOR, NMR, 20 STRUCTURES
1CVUA:33-73; B:2033-2073CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2
1CX2A:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558
1DDXA:33-73; B:1033-1073; C:2033-2073; D:3033-3073CRYSTAL STRUCTURE OF A MIXTURE OF ARACHIDONIC ACID AND PROSTAGLANDIN BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2: PROSTAGLANDIN STRUCTURE
1EGFA:1-53SOLUTION STRUCTURE OF MURINE EPIDERMAL GROWTH FACTOR DETERMINED BY NMR SPECTROSCOPY AND REFINED BY ENERGY MINIMIZATION WITH RESTRAINTS
1EPGA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPHA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPIA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1EPJA:1-53THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1KLOA:11-63; A:120-172; A:64-119CRYSTAL STRUCTURE OF THREE CONSECUTIVE LAMININ-TYPE EPIDERMAL GROWTH FACTOR-LIKE (LE) MODULES OF LAMININ GAMMA1 CHAIN HARBORING THE NIDOGEN BINDING SITE
1NPEB:738-790; B:847-899; B:791-846CRYSTAL STRUCTURE OF NIDOGEN/LAMININ COMPLEX
1PXXA:35-73; C:2033-2073; D:3033-3073; B:1033-1073CRYSTAL STRUCTURE OF DICLOFENAC BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2
1TLEA:1-58LE (LAMININ-TYPE EGF-LIKE) MODULE GIII4 IN SOLUTION AT PH 3.5 AND 290 K, NMR, 14 STRUCTURES
3EGFA:1-53SOLUTION STRUCTURE OF MURINE EPIDERMAL GROWTH FACTOR DETERMINED BY NMR SPECTROSCOPY AND REFINED BY ENERGY MINIMIZATION WITH RESTRAINTS
3PGHA:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, FLURBIPROFEN
4COXA:33-73; B:33-73; C:33-73; D:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, INDOMETHACIN
5COXA:33-73; B:33-73; C:33-73; D:33-73UNINHIBITED MOUSE CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2)
6COXA:33-73; B:33-73CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558 IN I222 SPACE GROUP
(-)
Human (Homo sapiens) (195)
1ADXA:1-40FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, 14 STRUCTURES
1APQA:23-75STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES
1AUTL:94-145; L:49-93HUMAN ACTIVATED PROTEIN C
1BF9A:45-85N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES
1C5MF:0-51STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1CVWL:90-144CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA)
1DQBA:1-46; A:47-83NMR STRUCTURE OF THROMBOMODULIN EGF(4-5)
1DVAL:49-85; M:49-85; L:86-142; M:86-142CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA
1DX5I:345-389; J:345-389; K:345-389; L:345-389; I:423-462; J:423-462; K:423-462; L:423-462; I:390-422; J:390-422; K:390-422; L:390-422CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX
1EZQB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515
1F0RB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
1F0SB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707
1F7EA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES
1F7MA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE
1FAKL:87-143; L:36-86HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
1FAXL:85-139COAGULATION FACTOR XA INHIBITOR COMPLEX
1FF7A:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES
1FFMA:45-90THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE
1FJSL:87-138CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA
1FSBA:1-40STRUCTURE OF THE EGF DOMAIN OF P-SELECTIN, NMR, 19 STRUCTURES
1G1QA:120-157; B:120-157; C:120-157; D:120-157CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS
1G1RA:120-157; B:120-157; C:120-157; D:120-157CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX
1G1SA:120-157; B:120-157P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE
1G1TA:120-157CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX
1G2LB:251-305FACTOR XA INHIBITOR COMPLEX
1G2MB:385-439FACTOR XA INHIBITOR COMPLEX
1HAEA:1-63HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, 20 STRUCTURES
1HAFA:1-63HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1HCGB:1-51STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION
1HJ7A:334-372; A:293-333NMR STUDY OF A PAIR OF LDL RECEPTOR CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 20 STRUCTURES
1HREA:175-241SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4
1HRFA:175-241SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4
1HZ8A:42-80; A:1-41SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR
1I0UA:42-82; A:1-41SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR
1IJQA:639-692; B:639-692CRYSTAL STRUCTURE OF THE LDL RECEPTOR YWTD-EGF DOMAIN PAIR
1IOEL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532
1IOXA:1-50NMR STRUCTURE OF HUMAN BETACELLULIN-2
1IP0A:1-50NMR STRUCTURE OF HUMAN BETACELLULIN-2
1IQEL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590
1IQFL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165
1IQGL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159
1IQHL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143
1IQIL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125
1IQJL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124
1IQKL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113
1IQLL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476
1IQML:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471
1IQNL:87-137HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192
1IVOC:5-51; D:5-51CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTH FACTOR AND RECEPTOR EXTRACELLULAR DOMAINS.
1J9CL:89-142; L:48-88CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
1JBUL:90-143COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183
1JL9B:6-50; A:6-47CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR
1K36A:1-46NMR STRUCTURE OF HUMAN EPIREGULIN
1K37A:1-46NMR STRUCTURE OF HUMAN EPIREGULIN
1KLIL:84-144COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA
1KLJL:89-144CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA
1KSNB:-1-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673
1KYE  [entry was replaced by entry 3LIW without any CATH domain information]
1L3YA:1-41INTEGRIN EGF-LIKE MODULE 3 FROM THE BETA-2 SUBUNIT
1LMJA:3-88NMR STUDY OF THE FIBRILLIN-1 CBEGF12-13 PAIR OF CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS
1LPGA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.
1LPKA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.
1LPZA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.
1LQDA:1A-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.
1MOXD:3-50; C:2-50CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA
1MQ5L:87-137CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1MQ6L:87-137CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL) AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL) METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1N7DA:333-377; A:295-332; A:643-693EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR
1NFUB:-2-49CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747
1NFWB:0-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685
1NFXB:-2-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944
1NFYB:-2-50CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095
1NQLB:3-50STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMAL GROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH) COMPLEX WITH EGF.
1NZIB:118-159; A:118-159CRYSTAL STRUCTURE OF THE CUB1-EGF INTERACTION DOMAIN OF COMPLEMENT PROTEASE C1S
1O5DL:89-142; L:47-88DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1P0SL:48-129CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R
1P9JA:1-54SOLUTION STRUCTURE AND DYNAMICS OF THE EGF/TGF-ALPHA CHIMERA T1E
1QFKL:86-144; L:49-85STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION
1RFNB:86-142HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE
1SZBA:126-168; B:126-168CRYSTAL STRUCTURE OF THE HUMAN MBL-ASSOCIATED PROTEIN 19 (MAP19)
1TOZA:411-453NMR STRUCTURE OF THE HUMAN NOTCH-1 LIGAND BINDING REGION
1TPGA:47-91F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)
1U8CB:1563-1604; B:1523-1562A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
1URKA:6-49SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
1UZJA:1486-1530; B:2486-2530; C:3486-3530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM.
1UZKA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, CA BOUND TO CBEGF23 DOMAIN ONLY
1UZPA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, SM BOUND FORM CBEGF23 DOMAIN ONLY.
1UZQA:1486-1530INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, APO FORM CBEGF23 DOMAIN ONLY.
1V3XB:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE
1W7XL:90-144FACTOR7 - 413 COMPLEX
1W8BL:88-143FACTOR7 - 413 COMPLEX
1WU1B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL) SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
1XFEA:39-83SOLUTION STRUCTURE OF THE LA7-EGFA PAIR FROM THE LDL RECEPTOR
1XKAL:86-135; L:49-85FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1XKBA:87-135; B:87-135; A:48-86; B:50-86FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1YGCL:90-142SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR
1YUFA:1-50TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 16 MODELS WITHOUT ENERGY MINIMIZATION
1YUGA:1-50TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 15 MODELS AFTER ECEPP/3 ENERGY MINIMIZATION
1Z6EL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3'-AMINO-1,2-BENZISOXAZOL-5'-YL)-N-(4-(2'-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (RAZAXABAN; DPC906; BMS-561389)
1ZAQA:1-44FOURTH EGF-LIKE DOMAIN OF THROMBOMODULIN, NMR, 12 STRUCTURES
2ADXA:1-40FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, MINIMIZED AVERAGE STRUCTURE
2B7DL:89-142; L:49-88FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON THROMBOSIS MODEL
2BMGA:-3-50CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50
2BOHA:-3-51CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND "1"
2BOKL:87-138FACTOR XA - CATION
2BQ6A:1A-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21
2BQ7A:-2-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43
2BQWA:-2-49CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45
2BZ6L:90-142ORALLY AVAILABLE FACTOR7A INHIBITOR
2CJIB:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2D1JB:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE
2EI6B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI7B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI8B:85-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL) CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2F9BL:89-142; L:49-88DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS
2FD6A:11-49STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
2FLBL:89-142; L:47-88DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
2FLRL:89-142; L:47-88NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS
2FZZL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE
2G00L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL)BENZAMIDE
2GD4A:87-138; L:86-139CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
2H9EL:89-136CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX
2I9AB:6-49; A:10-49; D:10-49; C:11-49CRYSTAL STRUCTURE OF THE FREE AMINOTERMINAL FRAGMENT OF UROKINASE TYPE PLASMINOGEN ACTIVATOR (ATF)
2I9BA:11-49; B:11-49; C:11-49; D:11-49CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX
2J2UB:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J34B:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J38B:-1-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J4IB:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J94B:-2-49CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J95B:-1-50CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2JKHL:87-140FACTOR XA - CATION INHIBITOR COMPLEX
2P16L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE
2P3FL:88-138CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX
2P3TA:87-138CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE
2P3UA:87-137CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL) AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663}
2P93L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
2P94L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE
2P95L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL) THIOPHENE-2-CARBOXAMIDE
2PHBB:0-50AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR
2PR3B:1-50FACTOR XA INHIBITOR
2PUQL:89-142; L:49-88CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR
2Q1JB:0-50THE DISCOVERY OF GLYCINE AND RELATED AMINO ACID-BASED FACTOR XA INHIBITORS
2RA0L:88-138X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE
2TGFA:1-50THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA
2UWLB:-2-49SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWOB:-2-49SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWPB:-2-49FACTOR XA INHIBITOR COMPLEX
2VH0B:-2-49STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS
2VH6B:-3-50STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS
2VVCL:87-138; K:86-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVUL:86-140AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVVL:87-140AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR
2VWLL:89-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWML:86-137; K:86-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWNL:88-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWOL:88-139AMINOPYRROLIDINE FACTOR XA INHIBITOR
2W26B:0A-49FACTOR XA IN COMPLEX WITH BAY59-7939
2W3IB:0-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2
2W3KB:0-50CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1
2W86A:1-45; A:106-147CRYSTAL STRUCTURE OF FIBRILLIN-1 DOMAINS CBEGF9HYB2CBEGF10, CALCIUM SATURATED FORM
2WPHE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT
2WPIE:87-145FACTOR IXA SUPERACTIVE DOUBLE MUTANT
2WPJE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED
2WPKE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED
2WPLE:87-145FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED
2WPME:87-145FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED
2XBVL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBWL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBXL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBYL:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC0L:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC4L:87-140FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC5L:89-139FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
3BT1A:8-49STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3BT2A:9-49STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3CENL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(2-(((5-CHLORO-2-PYRIDINYL) AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
3CFWA:120-156L-SELECTIN LECTIN AND EGF DOMAINS
3CS7L:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-METHOXYPHENYL)-6-(4-(1-(PYRROLIDIN-1-YLMETHYL)CYCLOPROPYL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3DEMA:121-164; B:121-164CUB1-EGF-CUB2 DOMAIN OF HUMAN MASP-1/3
3ELAL:89-142; L:48-88CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR
3ENSA:126-175; C:126-175; A:90-125; C:89-125CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE
3F1SB:87-137CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
3FFGL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR (R)-6-(2'-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4, 5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3GISY:348-389; X:349-389; Z:350-389; X:423-463; Y:423-463; Z:423-463; Z:390-422; X:390-422; Y:390-422CRYSTAL STRUCTURE OF NA-FREE THROMBIN IN COMPLEX WITH THROMBOMODULIN
3HPTA:126-175; C:126-175; C:89-125; A:90-125CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-(2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)ETHYL) AZEPAN-3-YL)GUANIDINE
3KCGL:84-137CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX
3KL6B:-1-48DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR
3KQBL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H- PYRAZOLE-5-CARBOXAMIDE
3KQCL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 6-(2'- (METHYLSULFONYL) BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL) PHENYL)-3-(TRIFLUOROMETHYL)-5,6- DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQDL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-(5-OXO-4,5- DIHYDRO-1H-1, 2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1- YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO- 1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQEL:87-138FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-METHYL-1-(3-(5- OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'- (PYRROLIDIN-1-YLMETHYL) BIPHENYL-4-YL)-5,6-DIHYDRO-1H- PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3LC3B:86-142; D:86-142BENZOTHIOPHENE INHIBITORS OF FACTOR IXA
3LC5B:86-139SELECTIVE BENZOTHIOPHINE INHIBITORS OF FACTOR IXA
3TGFA:1-50THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA
4TGFA:1-50SOLUTION STRUCTURES OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA DERIVED FROM 1*H NMR DATA
(-)
Malaria parasite p (Plasmodium falciparum) (1)
1CEJA:1-44; A:45-96SOLUTION STRUCTURE OF AN EGF MODULE PAIR FROM THE PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 1
(-)
Mouse (Mus musculus) (6)
1OB1C:1-44; F:1-44; C:45-96; F:45-97CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
3HS5A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3HS6A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF EICOSAPENTAENOIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3HS7A:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF DOCOSAHEXAENOIC ACID BOUND TO THE CYCLOOXYGENASE CHANNEL OF CYCLOOXYGENASE-2
3KRKA:33-73; B:33-73X-RAY CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF L531F MURINE COX-2
3LAQB:8-50; A:9-50STRUCTURE-BASED ENGINEERING OF SPECIES SELECTIVITY IN THE UPA-UPAR INTERACTION
(-)
Mus musculus. Organism_taxid: 10090 (1)
1GK5A:1-49SOLUTION STRUCTURE THE MEGF/TGFALPHA44-50 CHIMERIC GROWTH FACTOR
(-)
Norway rat (Rattus norvegicus) (1)
1NT0A:120-163; G:120-163CRYSTAL STRUCTURE OF THE CUB1-EGF-CUB2 REGION OF MASP2
(-)
Pig (Sus scrofa) (3)
1EAIC:1-61; D:1-61COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE
1PFXL:87-127; L:47-86PORCINE FACTOR IXA
1X7AL:86-127; L:50-85PORCINE FACTOR IXA COMPLEXED TO 1-{3-[AMINO(IMINO) METHYL]PHENYL}-N-[4-(1H-BENZIMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE
(-)
Pig roundworm (Ascaris suum) (4)
1ATAA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATBA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATDA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
1ATEA:1-62HIGH-RESOLUTION STRUCTURE OF ASCARIS TRYPSIN INHIBITOR IN SOLUTION: DIRECT EVIDENCE FOR A PH INDUCED CONFORMATIONAL TRANSITION IN THE REACTIVE SITE
(-)
Plasmodium cynomolgi. Organism_taxid: 5827. (1)
1B9WA:1-51; A:52-89C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI
(-)
Plasmodium knowlesi strain h. Organism_taxid: 5851. Strain: malayan h. (1)
1N1IA:8-54; B:8-54; D:8-54; C:9-54; C:55-101; B:55-100; A:55-98; D:55-94THE STRUCTURE OF MSP-1(19) FROM PLASMODIUM KNOWLESI
(-)
Plasmodium vivax (strain belem). Organism_taxid: 31273. Strain: belem. (1)
2NPRA:1-52; A:53-90STRUCTURAL STUDIES ON PLASMODIUM VIVAX MEROZOITE SURFACE PROTEIN-1
(-)
Sheep (Ovis aries) (18)
1CQEA:33-73; B:33-73PROSTAGLANDIN H2 SYNTHASE-1 COMPLEX WITH FLURBIPROFEN
1DIYA:33-73CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1
1EBVA:33-73OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID
1EQGA:33-73; B:33-73THE 2.6 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH IBUPROFEN
1EQHA:33-73; B:33-73THE 2.7 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH FLURBIPROFEN
1FE2A:33-73CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1HT5A:33-73; B:33-73THE 2.75 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH METHYL ESTER FLURBIPROFEN
1HT8A:33-73; B:33-73THE 2.7 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH ALCLOFENAC
1IGXA:33-73CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1IGZA:33-73CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.
1PGEA:33-73; B:33-73PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH P-(2'-IODO-5'-THENOYL) HYDROTROPIC ACID (IODOSUPROFEN)
1PRHA:33-73; B:33-73THE X-RAY CRYSTAL STRUCTURE OF THE MEMBRANE PROTEIN PROSTAGLANDIN H2 SYNTHASE-1
1PTHA:33-73; B:33-73THE STRUCTURAL BASIS OF ASPIRIN ACTIVITY INFERRED FROM THE CRYSTAL STRUCTURE OF INACTIVATED PROSTAGLANDIN H2 SYNTHASE
1Q4GA:33-73; B:33-732.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID
1U67A:33-73CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO A MUTANT OF PROSTAGLADIN H SYNTHASE-1 THAT FORMS PREDOMINANTLY 11-HPETE.
2AYLA:33-73; B:1033-10732.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX-RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN
2OYEP:33-73INDOMETHACIN-(R)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1
2OYUP:33-73INDOMETHACIN-(S)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1
(-)
Homologous Superfamily: reovirus attachment protein sigma1; domain 1 (4)
(-)
Human adenovirus 2. Organism_taxid: 10515. (1)
1QIUA:319-392; B:319-392; C:319-392; D:319-392; E:319-392; F:319-392A TRIPLE BETA-SPIRAL IN THE ADENOVIRUS FIBRE SHAFT REVEALS A NEW STRUCTURAL MOTIF FOR BIOLOGICAL FIBRES
(-)
Human adenovirus c, enterobacteria phage t4. Organism_taxid: 129951,10665. (1)
1V1IA:319-392ADENOVIRUS FIBRE SHAFT SEQUENCE N-TERMINALLY FUSED TO THE BACTERIOPHAGE T4 FIBRITIN FOLDON TRIMERISATION MOTIF WITH A LONG LINKER
(-)
Human adenovirus type 2, bacteriophage t4. (1)
1V1HE:319-392ADENOVIRUS FIBRE SHAFT SEQUENCE N-TERMINALLY FUSED TO THE BACTERIOPHAGE T4 FIBRITIN FOLDON TRIMERISATION MOTIF WITH A SHORT LINKER
(-)
Mammalian orthoreovirus 3. Organism_taxid: 10886. Strain: type 3 strain dearing. (1)
1KKEA:250-292; B:251-292; C:251-292CRYSTAL STRUCTURE OF REOVIRUS ATTACHMENT PROTEIN SIGMA1 TRIMER
(-)
Topology: left handed beta-beta-3-solenoid (10)
(-)
Homologous Superfamily: Cholin Binding (10)
(-)
Bacteriophage cp-1. Organism_taxid: 10747. (4)
1H09A:200-281MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1
1OBAA:200-281MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 COMPLEXED WITH CHOLINE
2J8FA:200-281CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT IN COMPLEX WITH A DISACCHARIDE-PENTAPEPTIDE)
2J8GA:200-281CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT IN COMPLEX WITH A TETRASACCHARIDE-PENTAPEPTIDE)
(-)
Cp-1 bacteriophage (Streptococcus phage cp-1) (2)
2IXUA:200-281CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (WILD-TYPE ENDOLYSIN)
2IXVA:200-281CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT)
(-)
Pneumococcus (Streptococcus pneumoniae) (1)
1GVME:196-318; D:194-318; A:192-318; C:192-318; B:186-318; F:185-318CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE
(-)
Streptococcus pneumoniae. Organism_taxid: 1313. (2)
1H8GA:224-318; B:225-318C-TERMINAL DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE
1HCXA:192-318; B:192-318CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE
(-)
Streptococcus pneumoniae. Organism_taxid: 1313. (1)
2BMLA:194-318; B:193-318OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL WALL DEGRADING VIRULENCE FACTORS
(-)
Topology: Leishmanolysin; domain 3 (1)
(-)
Homologous Superfamily: Leishmanolysin domain 3 (1)
(-)
Leishmania major. Organism_taxid: 5664. Strain: lrc-l119. (1)
1LMLA:394-460LEISHMANOLYSIN
(-)
Topology: Lipase, subunit A (8)
(-)
Homologous Superfamily: Lipase, subunit A (8)
(-)
Black mamba (Dendroaspis polylepis polylepis) (1)
1IMTA:1-80MAMBA INTESTINAL TOXIN 1, NMR, 39 STRUCTURES
(-)
Human (Homo sapiens) (1)
1N8SC:506-590STRUCTURE OF THE PANCREATIC LIPASE-COLIPASE COMPLEX
(-)
Pig (Sus scrofa) (5)
1ETHB:4-90; D:4-90TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX
1LPAA:6-90INTERFACIAL ACTIVATION OF THE LIPASE-PROCOLIPASE COMPLEX BY MIXED MICELLES REVEALED BY X-RAY CRYSTALLOGRAPHY
1LPBA:6-90THE 2.46 ANGSTROMS RESOLUTION STRUCTURE OF THE PANCREATIC LIPASE COLIPASE COMPLEX INHIBITED BY A C11 ALKYL PHOSPHONATE
1PCNA:1-93SOLUTION STRUCTURE OF PORCINE PANCREATIC PROCOLIPASE AS DETERMINED FROM 1H HOMONUCLEAR TWO-AND THREE-DIMENSIONAL NMR
1PCOA:1-93SOLUTION STRUCTURE OF PORCINE PANCREATIC PROCOLIPASE AS DETERMINED FROM 1H HOMONUCLEAR TWO-AND THREE-DIMENSIONAL NMR
(-)
Yellow-bellied toad (Bombina variegata) (1)
2KRAA:1-77SOLUTION STRUCTURE OF BV8
(-)
Topology: Pemi-like Protein 1; Chain: D (3)
(-)
Homologous Superfamily: [code=2.10.260.10, no name defined] (3)
(-)
Arabian camel (Camelus dromedarius) (1)
1MVFD:4-47; E:4-47MAZE ADDICTION ANTIDOTE
(-)
Bacillus subtilis (1)
1EKT  [entry was replaced by entry 1Z0R without any CATH domain information]
(-)
Escherichia coli. Organism_taxid: 562. (1)
1UB4C:402-476CRYSTAL STRUCTURE OF MAZEF COMPLEX
(-)
Topology: Porin MspA ribbon fold (1)
(-)
Homologous Superfamily: Porin MspA ribbon domain (1)
(-)
Mycobacterium smegmatis. Organism_taxid: 1772. (1)
1UUNA:72-123; B:72-123MAIN PORIN FROM MYCOBACTERIA SMEGMATIS (MSPA)
(-)
Topology: Rubredoxin-like (2)
(-)
Homologous Superfamily: YfgJ-like (2)
(-)
Escherichia coli. Organism_taxid: 562. (1)
2JNEA:1-71NMR STRUCTURE OF E.COLI YFGJ MODELLED WITH TWO ZN+2 BOUND. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER317.
(-)
Salmonella typhimurium lt2. Organism_taxid: 99287. Strain: lt2, sgsc1412. (1)
2JRPA:12-72SOLUTION NMR STRUCTURE OF YFGJ FROM SALMONELLA TYPHIMURIUM MODELED WITH TWO ZN+2 BOUND, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET STR86
(-)
Topology: Seminal Fluid Protein PDC-109 (Domain B) (33)
(-)
Homologous Superfamily: [code=2.10.10.10, no name defined] (13)
(-)
Bull (Bos taurus) (1)
1H8PA:66-109; B:66-109; A:22-61; B:22-61BULL SEMINAL PLASMA PDC-109 FIBRONECTIN TYPE II MODULE
(-)
Cattle (Bos taurus) (1)
1PDCA:-4-42REFINED SOLUTION STRUCTURE AND LIGAND-BINDING PROPERTIES OF PDC-109 DOMAIN B. A COLLAGEN-BINDING TYPE II DOMAIN
(-)
Human (Homo sapiens) (11)
1CK7A:344-390; A:228-280; A:286-332GELATINASE A (FULL-LENGTH)
1CXWA:1-60THE SECOND TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2
1E88A:102-160; A:44-101SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN
1E8BA:104-160; A:42-103SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN
1EAKA:336-391; A:220-276; B:220-276; C:220-276; B:336-391; D:220-276; A:277-335; B:277-335; C:277-335; D:277-335; C:336-391; D:336-391CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
1GXDA:315-361; B:257-303; A:199-251; B:199-251; B:315-361; A:257-303PROMMP-2/TIMP-2 COMPLEX
1J7MA:1-60THE THIRD FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2
1KS0A:1-59THE FIRST FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2
1L6JA:334-389; A:217-273; A:274-333CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B).
1QO6A:44-101SOLUTION STRUCTURE OF A PAIR OF MODULES FROM THE GELATIN-BINDING DOMAIN OF FIBRONECTIN
2FN2A:1-59SOLUTION NMR STRUCTURE OF THE GLYCOSYLATED SECOND TYPE TWO MODULE OF FIBRONECTIN, 20 STRUCTURES
(-)
Homologous Superfamily: [code=2.10.10.20, no name defined] (20)
(-)
3937 (Erwinia chrysanthemi str) (1)
1AIWA:1-62NMR STRUCTURES OF THE CELLULOSE-BINDING DOMAIN OF THE ENDOGLUCANASE Z FROM ERWINIA CHRYSANTHEMI, 23 STRUCTURES
(-)
Bacillus circulans. Organism_taxid: 1397. Strain: wl-12. (1)
1ED7A:655-699SOLUTION STRUCTURE OF THE CHITIN-BINDING DOMAIN OF BACILLUS CIRCULANS WL-12 CHITINASE A1
(-)
Serratia marcescens. Organism_taxid: 615. (13)
1E15B:449-499; A:449-498CHITINASE B FROM SERRATIA MARCESCENS
1E6NB:449-499; A:449-498CHITINASE B FROM SERRATIA MARCESCENS INACTIVE MUTANT E144Q IN COMPLEX WITH N-ACETYLGLUCOSAMINE-PENTAMER
1E6PA:449-499; B:449-499CHITINASE B FROM SERRATIA MARCESCENS INACTIVE MUTANT E144Q
1E6RB:449-499; A:449-498CHITINASE B FROM SERRATIA MARCESCENS WILDTYPE IN COMPLEX WITH INHIBITOR ALLOSAMIDIN
1E6ZB:449-499; A:449-498CHITINASE B FROM SERRATIA MARCESCENS WILDTYPE IN COMPLEX WITH CATALYTIC INTERMEDIATE
1GPFA:449-499; B:449-499CHITINASE B FROM SERRATIA MARCESCENS IN COMPLEX WITH INHIBITOR PSAMMAPLIN
1H0GB:449-499; A:449-498COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGADIN FROM CLONOSTACHYS
1H0IA:449-499; B:449-499COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN FROM GLIOCLADIUM
1O6IA:449-499; B:449-499CHITINASE B FROM SERRATIA MARCESCENS COMPLEXED WITH THE CATALYTIC INTERMEDIATE MIMIC CYCLIC DIPEPTIDE CI4.
1W1PA:449-499; B:449-499CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(GLY-L-PRO) AT 2.1 A RESOLUTION
1W1TA:449-499; B:449-499CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(HIS-L-PRO) AT 1.9 A RESOLUTION
1W1VA:449-499; B:449-499CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-ARG-L-PRO) AT 1.85 A RESOLUTION
1W1YA:449-499; B:449-499CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-TYR-L-PRO) AT 1.85 A RESOLUTION
(-)
Serratia marcescens. Organism_taxid: 615. Strain: bjl200 (1)
1GOIB:449-499; A:449-498CRYSTAL STRUCTURE OF THE D140N MUTANT OF CHITINASE B FROM SERRATIA MARCESCENS AT 1.45 A RESOLUTION
(-)
Serratia marcescens. Organism_taxid: 615. Strain: bjl200. (4)
1OGBA:449-499; B:449-499CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N
1OGGA:449-499; B:449-499CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N IN COMPLEX WITH INHIBITOR ALLOSAMIDIN
1UR8A:449-499; B:449-499INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE
1UR9A:449-499; B:449-499INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE
(-)
Topology: Tumor Necrosis Factor Receptor, subunit A; domain 2 (17)
(-)
Homologous Superfamily: Inosine monophosphate dehydrogenase (IMPDH) (1)
(-)
Corynebacterium glutamicum atcc 13032. Organism_taxid: 196627. Strain:dsm 20300, jcm 1318, lmg 3730, ncimb 10025. (1)
2QR6A:-5-15CRYSTAL STRUCTURE OF IMP DEHYDROGENASE/GMP REDUCTASE-LIKE PROTEIN (NP_599840.1) FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO AT 1.50 A RESOLUTION
(-)
Homologous Superfamily: Tumor Necrosis Factor Receptor, subunit A, domain 2 (16)
(-)
[unclassified] (1)
1ZA3R:62-101; S:62-101; R:21-61; S:21-61THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
(-)
Herpes simplex virus type 1 (Human herpesvirus 1) (1)
1JMAB:58-105; B:4-57CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM
(-)
Human (Homo sapiens) (13)
1D0GR:62-101; T:62-101; R:21-61; S:21-61; T:21-61; S:102-130; T:102-130; R:102-128; S:62-101CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL
1D4VA:115-154; A:69-114; A:155-185CRYSTAL STRUCTURE OF TRAIL-DR5 COMPLEX
1DU3A:62-101; A:21-61; B:21-61; C:21-61; G:21-61; H:21-61; I:21-61; B:62-101; C:62-101; B:102-130; G:102-128; G:62-101; H:62-101; I:62-101CRYSTAL STRUCTURE OF TRAIL-SDR5
1EXTA:98-148; B:11-97; B:98-148; A:13-97EXTRACELLULAR DOMAIN OF THE 55KDA TUMOR NECROSIS FACTOR RECEPTOR. CRYSTALLIZED AT PH3.7 IN P 21 21 21.
1FT4A:98-150; B:14-97; A:11-97; B:98-150PHOTOCHEMICALLY-ENHANCED BINDING OF SMALL MOLECULES TO THE TUMOR NECROSIS FACTOR RECEPTOR-1
1NCFA:98-150; B:14-97; A:11-97; B:98-150A NEW PARADIGM FOR TUMOR NECROSIS FACTOR SIGNALLING
1OSXA:17-42SOLUTION STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BLYS RECEPTOR 3 (BR3)
1SG1X:83-161; X:2-82CRYSTAL STRUCTURE OF THE RECEPTOR-LIGAND COMPLEX BETWEEN NERVE GROWTH FACTOR AND THE COMMON NEUROTROPHIN RECEPTOR P75
1TNRR:98-153; R:15-97CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
2AW2B:58-103; Y:58-103; B:2-57; Y:2-57CRYSTAL STRUCTURE OF THE HUMAN BTLA-HVEM COMPLEX
2H9GR:62-101; R:21-61CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
3BUKC:83-161; D:83-161; C:3-82; D:3-82CRYSTAL STRUCTURE OF THE NEUROTROPHIN-3 AND P75NTR SYMMETRICAL COMPLEX
(-)
Mouse (Mus musculus) (1)
3IJ2Y:83-161; X:83-163; X:2-82; Y:2-82LIGAND-RECEPTOR STRUCTURE
(-)
Topology: Umud Fragment, subunit A (13)
(-)
Homologous Superfamily: Umud Fragment, subunit A (13)
(-)
Enterobacteria phage lambda. Organism_taxid: 10710. (2)
1F39A:136-236; B:136-236CRYSTAL STRUCTURE OF THE LAMBDA REPRESSOR C-TERMINAL DOMAIN
1KCAA:136-236; B:136-236; C:136-236; D:136-236; E:136-236; F:136-236; G:136-236; H:136-236CRYSTAL STRUCTURE OF THE LAMBDA REPRESSOR C-TERMINAL DOMAIN OCTAMER
(-)
Escherichia coli bl21(de3). Organism_taxid: 469008. Strain: bl21(de3). (1)
1B12B:79-153,B:263-319; C:78-153,C:263-321; D:77-153,D:263-320; A:77-153,A:263-323CRYSTAL STRUCTURE OF TYPE 1 SIGNAL PEPTIDASE FROM ESCHERICHIA COLI IN COMPLEX WITH A BETA-LACTAM INHIBITOR
(-)
Escherichia coli k12. Organism_taxid: 83333. Strain: k-12. (1)
1KN9B:78-153,B:263-319; D:78-153,D:263-319; A:76-153,A:263-323; C:76-153,C:263-323CRYSTAL STRUCTURE OF A BACTERIAL SIGNAL PEPTIDASE APO-ENZYME, IMPLICATIONS FOR SIGNAL PEPTIDE BINDING AND THE SER-LYS DYAD MECHANISM.
(-)
Escherichia coli. Organism_taxid: 562 (1)
1AY9A:32-139; B:32-139WILD-TYPE UMUD' FROM E. COLI
(-)
Escherichia coli. Organism_taxid: 562. (6)
1I4VA:25-139; B:25-139SOLUTION STRUCTURE OF THE UMUD' HOMODIMER
1JHCA:75-204LEXA S119A C-TERMINAL TRYPTIC FRAGMENT
1JHEA:75-198; B:75-198LEXA L89P Q92W E152A K156A MUTANT
1JHFB:75-199; A:80-198LEXA G85D MUTANT
1JHHA:80-198; B:75-199LEXA S119A MUTANT
1T7DA:80-153,A:263-323; B:80-153,B:263-321CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH A LIPOPEPTIDE INHIBITOR
(-)
Escherichia coli. Organism_taxid: 562. (1)
1UMUB:32-137; A:32-136STRUCTURE DETERMINATION OF UMUD' BY MAD PHASING OF THE SELENOMETHIONYL PROTEIN
(-)
Escherichia coli. Organism_taxid: 83333. Strain: k-12. (1)
3IIQA:79-153,A:263-319; B:80-153,B:263-323CRYSTALLOGRAPHIC ANALYSIS OF BACTERIAL SIGNAL PEPTIDASE IN TERNARY COMPLEX WITH ARYLOMYCIN A2 AND A BETA-SULTAM INHIBITOR
(-)
Topology: Urease, subunit B (35)
(-)
Homologous Superfamily: Urease, subunit B (35)
(-)
Helicobacter pylori. Organism_taxid: 210. (2)
1E9YA:106-238CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE IN COMPLEX WITH ACETOHYDROXAMIC ACID
1E9ZA:106-238CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE
(-)
Klebsiella aerogenes. Organism_taxid: 28451. (10)
1A5KB:1-101K217E VARIANT OF KLEBSIELLA AEROGENES UREASE
1A5LB:1-101K217C VARIANT OF KLEBSIELLA AEROGENES UREASE
1A5MB:1-101K217A VARIANT OF KLEBSIELLA AEROGENES UREASE
1A5NB:1-101K217A VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL
1A5OB:1-101K217C VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL
1FWAB:1-101KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 7.5
1KRAB:1-101CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS
1KRBB:1-101CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS
1KRCB:1-101CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS
2KAUB:1-101THE CRYSTAL STRUCTURE OF UREASE FROM KLEBSIELLA AEROGENES AT 2.2 ANGSTROMS RESOLUTION
(-)
Klebsiella aerogenes. Organism_taxid: 28451. (17)
1EF2B:2001-2101CRYSTAL STRUCTURE OF MANGANESE-SUBSTITUTED KLEBSIELLA AEROGENES UREASE
1EJRB:2001-2101CRYSTAL STRUCTURE OF THE D221A VARIANT OF KLEBSIELLA AEROGENES UREASE
1EJSB:2001-2101CRYSTAL STRUCTURE OF THE H219N VARIANT OF KLEBSIELLA AEROGENES UREASE
1EJTB:2001-2101CRYSTAL STRUCTURE OF THE H219Q VARIANT OF KLEBSIELLA AEROGENES UREASE
1EJUB:2001-2101CRYSTAL STRUCTURE OF THE H320N VARIANT OF KLEBSIELLA AEROGENES UREASE
1EJVB:2001-2101CRYSTAL STRUCTURE OF THE H320Q VARIANT OF KLEBSIELLA AEROGENES UREASE
1EJWB:2001-2101CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 298K
1EJXB:2001-2101CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 100K
1FWBB:1-101KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 6.5
1FWCB:1-101KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 8.5
1FWDB:1-101KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 9.4
1FWEB:1-101KLEBSIELLA AEROGENES UREASE, C319A VARIANT WITH ACETOHYDROXAMIC ACID (AHA) BOUND
1FWFB:1-101KLEBSIELLA AEROGENES UREASE, C319D VARIANT
1FWGB:1-101KLEBSIELLA AEROGENES UREASE, C319S VARIANT
1FWHB:1-101KLEBSIELLA AEROGENES UREASE, C319Y VARIANT
1FWIB:1-101KLEBSIELLA AEROGENES UREASE, H134A VARIANT
1FWJB:1-101KLEBSIELLA AEROGENES UREASE, NATIVE
(-)
Sporosarcina pasteurii. Organism_taxid: 1474. (1)
1UBPB:5-126CRYSTAL STRUCTURE OF UREASE FROM BACILLUS PASTEURII INHIBITED WITH BETA-MERCAPTOETHANOL AT 1.65 ANGSTROMS RESOLUTION
(-)
Sporosarcina pasteurii. Organism_taxid: 1474. Strain: dms33. Sporosarcina pasteurii. Organism_taxid: 1474. (1)
1S3TB:5-126BORATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE
(-)
Sporosarcina pasteurii. Organism_taxid: 1474. Strain: dsm 33. (3)
2UBPB:5-126STRUCTURE OF NATIVE UREASE FROM BACILLUS PASTEURII
3UBPB:5-126DIAMIDOPHOSPHATE INHIBITED BACILLUS PASTEURII UREASE
4UBPB:5-126STRUCTURE OF BACILLUS PASTEURII UREASE INHIBITED WITH ACETOHYDROXAMIC ACID AT 1.55 A RESOLUTION
(-)
Sporosarcina pasteurii. Organism_taxid: 1474. Strain: dsm 33. Sporosarcina pasteurii. Organism_taxid: 1474. Strain: dsm 33. (1)
1IE7B:5-126PHOSPHATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE
(-)
Topology: Vascular Endothelial Growth Factor-165, Heparin-binding Domain (3)
(-)
Homologous Superfamily: Vascular Endothelial Growth Factor-165;Heparin-binding Domain; (3)
(-)
Human (Homo sapiens) (3)
1KMXA:1-55HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR
1VGHA:1-55HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, 20 STRUCTURES
2VGHA:1-55HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE